Enantioselective Syntheses of (-)-(R)-Rolipram, (-)-(R)-Baclofen and Other GABA Analogues via Rhodium-Catalyzed Conjugate Addition of Arylboronic Acids

Abstract

Highly enantioselective syntheses of two important γ-aminobutyric acid (GABA) analogues, the antispastic drug (-)-(R)-Baclofen and the antidepressant agent (-)-(R)-Rolipram, are reported. Key-steps in both syntheses are the Rh-catalyzed asymmetric 1,4-additions of arylboronic acids to 4-aminobut-2,3-enoic acid derivatives.

asymmetric synthesis - catalysis - conjugate addition - rhodium - arylboronic acid

References

1a Mann A. Boulanger T. Brandau B. Durant F. Evrard G. Heaulme M. Desaulles E. Wermuth C.-G. J. Med. Chem.  1991,  34:  1307 

1b Karla R. Ebert B. Thorkildsen C. Herdeis C. Johansen TN. Nielsen B. Krogsgaard-Larsen P. J. Med. Chem.  1999,  42:  2053 

2 Olpe HR. Demiéville H. Baltzer V. Bencze WL. Eur. J. Pharmacol.  1978,  52:  133 

3 Diaz A. Siro JG. García-Navío JL. Vaquero JJ. Alvarez-Builla J. Synthesis  1997,  559 

4a Herdeis C. Hubmann HP. Tetrahedron: Asymmetry  1992,  3:  1213 

4b Langlois N. Dahuron N. Wang H.-S. Tetrahedron  1996,  52:  15117 

4c Licandro E. Maiorana S. Baldoli C. Capella L. Perdicchia D. Tetrahedron: Asymmetry  2000,  11:  975 

4d Schoenfelder A. Mann A. Le Coz S. Synlett  1993,  63 

4e Thakur VV. Nikalje MD. Sudalai A. Tetrahedron: Asymmetry  2003,  14:  581 

4f Corey EJ. Zhang F.-Y. Org. Lett.  2000,  2:  4257 

4g Anada M. Hashimoto S.-I. Tetrahedron Lett.  1998,  39:  79 

4h Resende P. Almeida WP. Coelho F. Tetrahedron: Asymmetry  1999,  10:  2113 

4i Wang M.-X. Zhao S.-M. Tetrahedron Lett.  2002,  43:  6617 

4j Brenna E. Caraccia N. Fuganti C. Fuganti D. Grasseli P. Tetrahedron: Asymmetry  1997,  8:  3801 

4k Belda O. Lundgren S. Moberg C. Org. Lett.  2003,  5:  2275 

5a Yoon CH. Nagle A. Chen C. Gandhi D. Jung KW. Org. Lett.  2003,  5:  2259 

5b Braun M. Opdenbusch K. Unger C. Synlett  1995,  1174 

5c Meyers AI. Snyder L. J. Org. Chem.  1993,  58:  36 

5d Mulzer J. Zuhse R. Schmiechen R. Angew. Chem.  1992,  104:  914 

5e Barluenga J. Fernández-Rodríguez MA. Aguilar E. Fernández-Marí F. Salinas A. Olano B. Chem. Eur. J.  2001,  7:  3533 

5f Anada M. Mita O. Watanabe H. Kitagaki S. Hashimoto S. Synlett  1999,  11:  1775 

6 For a preliminary report on part of the work described here, see: Meyer O. Becht J.-M. Helmchen G. Synlett  2003,  1539 

7 Sakai M. Hayashi H. Miyaura N. Organometallics  1997,  16:  4229 

8a Takaya Y. Ogasawara M. Hayashi T. Sakai M. Miyaura N. J. Am. Chem. Soc.  1998,  120:  5579 

8b Takaya Y. Senda T. Kurushima H. Ogasawara M. Hayashi T. Tetrahedron: Asymmetry  1999,  10:  4047 

8c Fagnou K. Lautens M. Chem. Rev.  2003,  103:  169 

9 De Vita RJ. Frontier AJ. Schoen WR. Wyvratt MJ. Fisher MH. Cheng K. Chan WW.-S. Butler BS. Smith RG. Helv. Chim. Acta  1997,  80:  1244 

10a Frigerio M. Santagostino M. Sputore S. J. Org. Chem.  1999,  64:  4537 

10b More JD. Finney NS. Org. Lett.  2002,  4:  3001 

10c Chhabra SR. Mahajan A. Chan WC. J. Org. Chem.  2002,  67:  4017 

10d Àlvarez M. Fernández D. Joule JA. Tetrahedron Lett.  2001,  42:  315 

11a Sakuma S. Sakai M. Itooka R. Miyaura N. J. Org. Chem.  2000,  65:  5951 

11b Itooka R. Iguchi Y. Miyaura N. J. Org. Chem.  2003,  68:  6000 

12 Ishiyama T. Murata M. Miyaura N. J. Org. Chem.  1995,  60:  7508 

13 Falck JR. Bondlela M. Venkataraman SK. Srinivas D. J. Org. Chem.  2001,  66:  7148 

14 Langlois N. Wang H.-S. Synth. Commun.  1997,  27:  3133 

15 Lintunen T. Yli-Kauhaluoma JT. Bioorg. Med. Chem. Lett.  2000,  15:  1749 

16 Mattingly PG. Synthesis  1990,  367 

17 Note added in proof: Using a hydroxorhodium catalyst, generated in situ, recently developed (compound 8 in: Hayashi T. Takahashi M. Takaya Y. Ogasawara M. J. Am. Chem. Soc.  2002,  124:  5052 ), the reaction of 3a with 6a proceeded at 70 °C (other conditions as in entry 3 of Table 1) within 1 h to give (S)-7a in 70% isolated yield with 95%ee. Accordingly, use of the new catalyst would likely allow an improvement for all reactions described here